Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer.
Sobral-Leite M, Castillo S, Vonk S, Melillo X, Lam N, de Bruijn B, Hagos Y, Sanders J, Almekinders M, Visser L, Groen E, Kristel P, Ercan C, Azarang L, Yuan Y; Grand Challenge PRECISION Consortium; Menezes R, Lips E, Wesseling J.
Sobral-Leite M, et al. Among authors: ercan c.
Res Sq [Preprint]. 2023 Dec 13:rs.3.rs-3639521. doi: 10.21203/rs.3.rs-3639521/v1.
Res Sq. 2023.
PMID: 38168198
Free PMC article.
Preprint.